AHL Partners’s AbbVie ABBV Stock Holding History

AHL Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$6.42M	Sell	66,435 -15,426	-19%	-$1.45M	0.1%	389
2017 Q3	$7.27M	Buy	81,861 +4,808	+6%	+$366K	0.13%	280
2017 Q2	$5.59M	Buy	77,053 +21,280	+38%	+$1.43M	0.12%	312
2017 Q1	$3.63M	Buy	55,773 +23,445	+73%	+$1.47M	0.08%	445
2016 Q4	$2.02M	Buy	32,328 +8,210	+34%	+$501K	0.06%	506
2016 Q3	$1.52M	Buy	24,118 +14,959	+163%	+$968K	0.06%	463
2016 Q2	$567K	Buy	9,159 +3,685	+67%	+$225K	0.03%	580
2016 Q1	$313K	Sell	5,474 -34,044	-86%	-$1.9M	0.02%	666
2015 Q4	$2.34M	Buy	+39,518	New	+$2.28M	0.18%	209
2015 Q3	–	Sell	-73,116	Closed	-$4.91M	–	676
2015 Q2	$4.91M	Sell	73,116 -18,633	-20%	-$1.22M	0.2%	185
2015 Q1	$5.37M	Buy	91,749 +51,158	+126%	+$3.09M	0.21%	142
2014 Q4	$2.66M	Buy	40,591 +33,032	+437%	+$2.08M	0.14%	310
2014 Q3	$437K	Buy	+7,559	New	+$420K	0.03%	515

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AHL Partners's ABBV Position: Q4 2017 in Review

AHL Partners reduced its AbbVie (ABBV) stake by 19% in Q4 2017, selling an estimated $1.45M and leaving 66,435 shares worth $6.42M. The position accounts for 0.1% of the portfolio, ranked #389.

AHL Partners first reported a position in ABBV in Q3 2014 and has held it in 13 quarters since. The position peaked at $7.27M in Q3 2017. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

AHL Partners held 66,435 shares of AbbVie worth $6.42M as of Q4 2017.
AHL Partners sold 15,426 AbbVie shares in Q4 2017, an estimated $1.45M.
AbbVie made up 0.1% of AHL Partners's portfolio in Q4 2017, its #389 holding.
AHL Partners first reported a position in AbbVie in Q3 2014 and has held it in 13 quarters since.
AHL Partners's AbbVie position peaked at $7.27M in Q3 2017.
2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.